Because of the importance of p53 mutations and loss of p53 function being linked with poor outcomes in SCCHN [3], we considered the possibility that inhibiting glycolysis would potentiate radiation sensitivity in p53 mutant cells as a result of their increased dependence on glycolysis. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.